Evidence map›Paper›PMID 24002181›Full record

ArticleJournal of neuro-oncology2013

Heparin blocks transfer of extracellular vesicles between donor and recipient cells.

Nadia A Atai, Leonora Balaj, Henk van Veen, Xandra O Breakefield, Peter A Jarzyna, Cornelis J F Van Noorden, Johan Skog, Casey A Maguire

Open access · greenAbstract read
In one paragraph

Article in Journal of neuro-oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 196 citations in OpenAlex.

  1. Isolation of biologically-active exosomes from human plasma.Journal of immunological methods · 2014
    Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Current Understanding of the Exosomes and Their Associated Biomolecules in the Glioblastoma Biology, Clinical Treatment, and Diagnosis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Nadia A AtaiDepartment of Neurology and Program in Neuroscience, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Leonora Balaj
Henk van Veen
Xandra O Breakefield
Peter A Jarzyna
Cornelis J F Van Noorden
Johan Skog
Casey A Maguire
Harvard University · USAcademic Medical Center · NLAthinoula A. Martinos Center for Biomedical Imaging · USExosome Diagnostics (United States) · USUniversity of Amsterdam · NL

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHAREST, ALAIN · 1996 to 2021
$30.9M
Interdepartmental Neuroscience CenterP30NS045776 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS, TANNOUS, BAKHOS A · 2003 to 2018
$11.1M
Tumor exosomes as agents of genetic changeR01CA141150 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS · 2009 to 2011
$873k
A hybrid microvesicle/virus vector for targeted gene transfer to the brainR21NS081374 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MAGUIRE, CASEY A · 2012 to 2013
$449k
Serum exosome diagnosis for gliomaR21CA141226 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS · 2009 to 2010
$424k
Serum exosome biomarkers for evaluation of glioma drug responseR21CA156009 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS · 2011 to 2012
$423k
NCI NIH HHS CA069246NCI NIH HHS CA141150NCI NIH HHS CA141226NCI NIH HHS CA156009NCI NIH HHS P01 CA069246NCI NIH HHS R01 CA141150NCI NIH HHS R21 CA141226NCI NIH HHS R21 CA156009NINDS NIH HHS 1 R21 NS081374-01NINDS NIH HHS P30 NS045776NINDS NIH HHS P30NS045776NINDS NIH HHS R21 NS081374
6 · The paper itself

Abstract

Extracellular vesicles (EVs) have been implicated in tumorigenesis. Biomolecules which can block EV binding and uptake into recipient cells may be of therapeutic value as well as enhance understanding of EV biology. Here, we show that heparin interacts with uptake of tumor-derived as well as non-tumor-derived EVs into recipient cells. Incubation of glioma cell-derived EVs with heparin resulted in micron-sized structures observed by transmission electron microscopy, with EVs clearly visible within these structures. Inclusion of heparin greatly diminished transfer of labeled EVs from donor to recipient tumor cells. We also show a direct interaction between heparin and EVs using confocal microscopy. We found that the block in EV uptake was at the level of cell binding and not internalization. Finally, incubation of glioma-derived EVs containing EGFRvIII mRNA with heparin reduced transfer of this message to recipient cells. The effect of heparin on EVs uptake may provide a unique tool to study EV function. It may also foster research of heparin or its derivatives as a therapeutic for disease in which EVs play a role.

Indexed as

AnticoagulantsErbB ReceptorsExtracellular SpaceFlow CytometryGlioblastomaHeparinHumansReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerTransport VesiclesTumor Cells, CulturedAnticoagulantsepidermal growth factor receptor VIIIErbB ReceptorsHeparinRNA, Messenger

Identifiers

PMID24002181
PMCPMC3856724
OpenAlexW2086500857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.